Records 1 - 30
| Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer.
Cancers 2022 Aug 14 (17): .
Herzog Henrike, Dogan Senol, Aktas Bahriye, Nel Ivon
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.
Breast (Edinburgh, Scotland) 2022 Jan 62 52-60.
Lee Soohyeon, Park Kyunghee, Kim Gun Min, Jung Kyung Hae, Kang Seok Yun, Park In Hae, Kim Jee Hyun, Ahn Hee Kyung, Park Woong-Yang, Im Seock-Ah, Park Yeon H
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers.
Frontiers in oncology 2022 12 819555.
Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu
| Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
American journal of human genetics 2022 08 109 (8): 1520-1533.
Brewer Takae, Yehia Lamis, Bazeley Peter, Eng Char
| Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Annals of medicine 2021 Dec 53 (1): 1358-1369.
Wang Liye, Zhai Qinglian, Lu Qianyi, Lee Kaping, Zheng Qiufan, Hong Ruoxi, Wang Shus
| Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer.
The oncologist 2021 Jul .
Al-Shamsi Humaid O, Abu-Gheida Ibrahim, Abdulsamad Ahmed S, AlAwadhi Aydah, Alrawi Sadir, Musallam Khaled M, Arun Banu, Ibrahim Nuhad
| Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study.
Breast cancer research and treatment 2021 Jun .
Kim Haeyoung, Kim Yeon Jeong, Park Donghyun, Park Woong-Yang, Choi Doo Ho, Park Won, Cho Won Kyung, Kim Nal
| Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer.
Scientific reports 2021 Apr 11 (1): 8109.
Hagio Kanako, Amano Toraji, Hayashi Hideyuki, Takeshita Takashi, Oshino Tomohiro, Kikuchi Junko, Ohhara Yoshihito, Yabe Ichiro, Kinoshita Ichiro, Nishihara Hiroshi, Yamashita Hiro
| Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast Cancer.
Anticancer research 2021 Apr 41 (4): 2133-2140.
Sasaki Ritsuko, Horimoto Yoshiya, Yanai Yuka, Kurisaki-Arakawa Aiko, Arakawa Atsushi, Nakai Katsuya, Saito Mitsue, Saito Tsuyos
| Extended gene panel testing in lobular breast cancer.
Familial cancer 2021 Mar .
van Veen Elke M, Evans D Gareth, Harkness Elaine F, Byers Helen J, Ellingford Jamie M, Woodward Emma R, Bowers Naomi L, Wallace Andrew J, Howell Sacha J, Howell Anthony, Lalloo Fiona, Newman William G, Smith Miriam
| Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients.
Scientific reports 2021 Mar 11 (1): 6761.
Muendlein Axel, Geiger Kathrin, Gaenger Stella, Dechow Tobias, Nonnenbroich Christoph, Leiherer Andreas, Drexel Heinz, Gaumann Andreas, Jagla Wolfgang, Winder Thomas, Mayer Frank, Decker Thom
| A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.
Annals of translational medicine 2021 Feb 9 (4): 301.
Huang Liang, Lang Guan-Tian, Liu Qi, Shi Jin-Xiu, Shao Zhi-Ming, Cao A-Yo
| DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis.
Annals of translational medicine 2021 Feb 9 (3): 220.
Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing
| Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Neurosurgery 2020 Dec .
Dono Antonio, Takayasu Takeshi, Yan Yuanqing, Bundrant Bethany E, Arevalo Octavio, Lopez-Garcia Carlos A, Esquenazi Yoshua, Ballester Leomar
| Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers.
JNCI cancer spectrum 2020 Dec 4 (6): pkaa094.
Yao K Katharine A, Clifford Jacob, Li Shuwei, LaDuca Holly, Hulick Peter, Gutierrez Stephanie, Black Mary Hel
| Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Cancers 2020 Aug 12 (9): .
Fanale Daniele, Incorvaia Lorena, Filorizzo Clarissa, Bono Marco, Fiorino Alessia, Calò Valentina, Brando Chiara, Corsini Lidia Rita, Barraco Nadia, Badalamenti Giuseppe, Russo Antonio, Bazan Vivia
| Targeted next generation sequencing identifies somatic mutations in a cohort of Egyptian breast cancer patients.
Journal of advanced research 2020 Jul 24 149-157.
Nassar Auhood, Abouelhoda Mohamed, Mansour Osman, Loutfy Samah A, Hafez Mohamed M, Gomaa M, Bahnassy Abeer, El-Din Youssef Amira Salah, Lotfy Mai M, Ismail Hoda, Ahmed Ola S, Abou-Bakr Amany Abd-Elhameed, Zekri Abdel-Rahman
| Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 Jun .
Sun Xiangjie, Zuo Ke, Yao Qianlan, Zhou Shuling, Shui Ruohong, Xu Xiaoli, Bi Rui, Yu Baohua, Cheng Yufan, Tu Xiaoyu, Lu Hongfen, Yang Went
| Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Cancer medicine 2020 Apr .
Welt Anja, Wiesweg Marcel, Theurer Sarah, Abenhardt Wolfgang, Groschek Matthias, Müller Lothar, Schröder Jan, Tewes Mitra, Chiabudini Marco, Potthoff Karin, Bankfalvi Agnes, Marschner Norbert, Schuler Martin, Breitenbücher Fra
| Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
Breast cancer research and treatment 2020 Apr .
Zeng Chenjie, Guo Xingyi, Wen Wanqing, Shi Jiajun, Long Jirong, Cai Qiuyin, Shu Xiao-Ou, Xiang Yongbin, Zheng W
| Gene Panel Testing in Hereditary Breast Cancer.
Archives of Iranian medicine 2020 Mar 23 (3): 155-162.
Rostami Parvin, Zendehdel Kazem, Shirkoohi Reza, Ebrahimi Elmira, Ataei Mitra, Imanian Hashem, Najmabadi Hossein, Akbari Mohammad Reza, Sanati Mohammad Hosse
| The frequency of PTEN germline mutations in Chinese breast cancer patients: The PTEN gene may not be closely associated with breast cancer in the Chinese population.
Gene 2020 Mar 144630.
Wu Yu, Huang Dabing, Zhang Huanhuan, Weng Xiaoling, Wang Honglian, Zhou Qinghua, Wu Ying, Shen Yi, Sun Baining, Hu Zh
| Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
Aging 2020 Feb 12 .
Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni
| Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer.
International journal of molecular sciences 2020 Feb 21 (4): .
Winn Jennifer S, Hasse Zachary, Slifker Michael, Pei Jianming, Arisi-Fernandez Sebastian M, Talarchek Jacqueline N, Obeid Elias, Baldwin Donald A, Gong Yulan, Ross Eric, Cristofanilli Massimo, Alpaugh R Katherine, Fernandez Sandra
| Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.
The Journal of molecular diagnostics : JMD 2020 Feb .
Kwong Ava, Shin Vivian Yvonne, Chen Jiawei, Wai-Yin Cheuk Isabella, Ho Cecilia Ys, Au Chun Hang, Chan Karen K L, Ngan Hextan Y S, Chan Tsun Leung, Ford James M, Ma Edmond
| Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Feb .
Barroso-Sousa Romualdo, Keenan Tanya E, Pernas Sonia, Exman Pedro, Jain Esha, Garrido-Castro Ana C, Hughes Melissa E, Bychkovsky Brittany, Umeton Renato, Files Janet L, Lindeman Neal I, MacConaill Laura E, Hodi F Stephen, Krop Ian, Dillon Deborah A, Winer Eric P, Wagle Nikhil, Lin Nancy U, Mittendorf Elizabeth A, Van Allen Eliezer M, Tolaney Sara
| Multigene panel testing results in patients with multiple breast cancer primaries.
The breast journal 2020 Jan .
Corredor Jessica, Woodson Ashley H, Gutierrez Barrera Angelica, Arun Ba
| Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
Polish journal of pathology : official journal of the Polish Society of Pathologists 2020 71 (1): 7-12.
Mitus Jerzy, Adamczyk Agnieszka, Majchrzyk Kaja, Kowalik Artur, Rys Janusz, Niemiec Joan
| Exploration of intermediate-sized INDELs by next-generation multigene panel testing in Han Chinese patients with breast cancer.
Human genome variation 2019 6 51.
Hata Chihiro, Nakaoka Hirofumi, Xiang Yu, Wang Dong, Yang Anping, Liu Dahai, Liu Fang, Zou Qingfeng, Zheng Ke, Inoue Ituro, You H
| Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.
Cancer genomics & proteomics 0 19 (4): 464-476.
Stella Stefania, Vitale Silvia Rita, Massimino Michele, Motta Gianmarco, Longhitano Claudio, Lanzafame Katia, Martorana Federica, Fazzari Carmine, Vecchio Giada Maria, Tirrò Elena, Inzerilli Nicola, Carciotto Rosaria, Manzella Livia, Caruso Michele, Vigneri Pao